Click to Skip Ad
Closing in...

Motorola KORE could be vendor's upcoming quad-core tablet

Updated Dec 19th, 2018 7:24PM EST
BGR

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs.

Motorola is rumored to be working on a new tablet with Android 4.0 Ice Cream Sandwich a 4:3 aspect ratio like Apple’s iPad. Fusible did a bit of digging on Friday and found that the upcoming slate could be dubbed the “Motorola KORE.” Motorola Trademark Holdings on Wednesday register five new domains: MotorolaKore.com, KoreMotorola.com,  Motokore.com, MotoKore.com and Motorola-Kore.com. Fusible speculates that these domains are being held for the launch of Motorola Mobility’s second Android-powered tablet. Earlier rumors suggested the slate would be dubbed the XOOM 2, but following a tepid reception, it is entirely possible that Motorola could dump the brand for the slightly edgier “KORE” moniker. Also of note, Motorola’s next tablet could be one of the first slates to ship with NVIDIA’s quad-core Kal-El processor, so we wouldn’t be surprised if Moto intended to make those four “kores” the main focus of its marketing campaign.Motorola released its XOOM tablet in the U.S. this past March and while sales haven’t been stellar, the slate has fared relatively well compared to other Android tablets on the market with 250,000 units shipped in the first quarter

.

Read

Zach Epstein
Zach Epstein Executive Editor

Zach Epstein has been the Executive Editor at BGR for more than 15 years. He manages BGR’s editorial team and ensures that best practices are adhered to. He also oversees the Ecommerce team and directs the daily flow of all content. Zach first joined BGR in 2007 as a Staff Writer covering business, technology, and entertainment.

His work has been quoted by countless top news organizations, and he was recently named one of the world's top 10 “power mobile influencers” by Forbes. Prior to BGR, Zach worked as an executive in marketing and business development with two private telcos.